GammaTile
1 known investors
GammaTile is an FDA-cleared, bioresorbable collagen tile embedded with radiation sources that is implanted during brain tumor removal surgery to deliver targeted radiation to remaining cancer cells. It is indicated for patients with operable, newly diagnosed and recurrent brain tumors such as glioblastoma, brain metastases, and meningiomas.
BiotechHealthtechMedical Devices
Founders & leadership
PL
Per LangoeinChief Executive OfficerPer Langoe is Chief Executive Officer of GT Medical Technologies, Inc., a role he took on in 2024. He previously served as President and CEO of Palette Life Sciences, chairman of the board at ProstaLund AB and AdvaVet, a partner at Langoe Strategic Advisors, and head of M&A for Nestlé Skin Health.
DG
David G. Brachman, MD, FASTROCo-Founder and Chief Technology Officer
HM
Heyoung McBride, MD, MS, FASTROCo-Founder
PN
Peter Nakaji, MDinCo-FounderPeter Nakaji, MD is a neurosurgeon and executive director at Scottsdale Neurosurgery Specialists, and a professor at the University of Arizona College of Medicine – Phoenix and the ASU John Shufeldt School of Medicine and Medical Engineering. He chaired the neurosurgery department at UA College of Medicine – Phoenix and directed Banner Health's Neuroscience Institute from 2019 to 2025, following years of practice with Barrow Neurosurgical Associates and St. Joseph's Hospital and Medical Center.
EY
Emad Youssef, MDCo-Founder
TT
Theresa Thomas, MS, CCRCCo-Founder
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountSeries DAug 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does GammaTile do?
- GammaTile is an FDA-cleared, bioresorbable collagen tile embedded with radiation sources that is implanted during brain tumor removal surgery to deliver targeted radiation to remaining cancer cells. It is indicated for patients with operable, newly diagnosed and recurrent brain tumors such as glioblastoma, brain metastases, and meningiomas.
- Who are GammaTile's investors?
- GammaTile's investors include Accelmed Partners.